Aterian (ATER) Q4 2024 earnings summary

Executive summary

• Achieved a significant turnaround in 2024, reducing adjusted EBITDA loss from $22.3M in 2023 to $2.1M in 2024, a 91% improvement, with narrowed net and operating losses and improved margins.

• Streamlined product portfolio to six core brands, optimized go-to-market strategy, and strengthened supply chain, driving operational efficiency.

• Cash flow from operations turned positive in 2024, debt reduced by over $4M, and inventory right-sized for profitability.

• Net revenue for Q4 2024 was $24.6M, down 25% year-over-year due to SKU rationalization, but only a 4% decline when adjusted.

• 2025 growth expected from new product launches and expanded sales channels, despite tariff headwinds.

Financial highlights

• Adjusted EBITDA loss for 2024 was $2.1M, down from $22.3M in 2023.

• Q4 2024 net revenue was $24.6M, down from $32.8M year-over-year, due to SKU rationalization and lower liquidation.

• Q4 gross margin improved to 63.4% from 51.0%; contribution margin rose to 19.4% from -0.8%.

• Full-year 2024 net revenue was $99.0M, down from $142.6M; gross margin increased to 62.1% from 49.3%.

• Year-end 2024 cash balance was $18.0M, down from $20.0M prior year; cash flow from operations improved to $2.2M from ($13.4M).

Outlook and guidance

• 2025 net revenue expected between $104M and $106M, a 5–7% increase over 2024; pro forma growth of 9–12% excluding discontinued SKUs.

• 2025 Adjusted EBITDA projected to be near break-even, including $3.5M tariff impact.

• Three-year CAGR (2025-2027) expected at 10-12%, driven by new products, omnichannel expansion, and international growth.

• Ending 2025 cash projected at $16M-$17M.

• Management confident in mitigating tariff effects and achieving long-term growth and profitability.